Skip links

Epilepsy: Our Immediate Focus

Around 50 million people worldwide struggle with epilepsy, making it one of the most common neurological diseases globally.

1 in every 3 Patients are untreatable with medication.

“Novela is currently collaborating with Universities, Hospitals and Institutions to develop effective treatments and stop dangerous seizures from occurring. We believe we will have a human medical treatment in the next 24 months”

Ray Iskander, Novela CEO

How Epilepsy is Treated with Neureka™

When an oncoming seizure is detected our interface sends a tiny electric current instructing the brain to stop the seizure before it occurs. We have successfully demonstrated this at the Hospital for Sick Children in Toronto, where we were able to detect seizures at near 100% accuracy, more than 2 minutes before onset. Using neuromodulation we completely stopped seizures in nearly 85% of all cases.

Investigating Epilepsy with Neureka™

Novela’s Avertus EEG Module detects seizures before they occur and captures data that accelerates development of dynamiceutical treatments and predictive markers for Sudden Unexpected Death in Epilepsy (SUDEP)